Core Insights - The stock price of Shangrong Medical (002551) closed at 4.59 yuan on August 25, 2025, reflecting a decrease of 0.86% with a turnover rate of 8.57% and a trading volume of 523,800 hands, amounting to 241 million yuan in transaction value [1] Financial Performance - For the latest financial period ending in mid-2025, Shangrong Medical reported total operating revenue of 528 million yuan, a year-on-year decrease of 16.38% [1] - The net profit attributable to shareholders was 7.76 million yuan, down 155.31% year-on-year, while the non-recurring net profit was 12.52 million yuan, a decline of 642.19% [1] - The company's liquidity ratios include a current ratio of 2.450 and a quick ratio of 2.098, with a debt-to-asset ratio of 21.99% [1] Company Background - Shangrong Medical, established in 1998 and located in Shenzhen, primarily engages in the manufacturing of specialized equipment [2] - The company has a registered capital of approximately 844.63 million yuan and a paid-in capital of about 820.29 million yuan, with Liang Guiqiu serving as the legal representative [1][2] - The company has made investments in 17 enterprises, participated in 52 bidding projects, and holds 9 trademark registrations and 121 patents, along with 40 administrative licenses [2]
尚荣医疗(002551)8月25日主力资金净流出3216.13万元